Endothelial glycocalyx during early reperfusion in patients undergoing cardiac surgery

Experimental cardiac ischemia-reperfusion injury causes degradation of the glycocalyx and coronary washout of its components syndecan-1 and heparan sulfate. Systemic elevation of syndecan-1 and heparan sulfate is well described in cardiac surgery. Still, the events during immediate reperfusion after...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2021-05, Vol.16 (5), p.e0251747-e0251747
Hauptverfasser: Passov, Arie, Schramko, Alexey, Salminen, Ulla-Stina, Aittomäki, Juha, Andersson, Sture, Pesonen, Eero
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e0251747
container_issue 5
container_start_page e0251747
container_title PloS one
container_volume 16
creator Passov, Arie
Schramko, Alexey
Salminen, Ulla-Stina
Aittomäki, Juha
Andersson, Sture
Pesonen, Eero
description Experimental cardiac ischemia-reperfusion injury causes degradation of the glycocalyx and coronary washout of its components syndecan-1 and heparan sulfate. Systemic elevation of syndecan-1 and heparan sulfate is well described in cardiac surgery. Still, the events during immediate reperfusion after aortic declamping are unknown both in the systemic and in the coronary circulation. In thirty patients undergoing aortic valve replacement, arterial concentrations of syndecan-1 and heparan sulfate were measured immediately before and at one, five and ten minutes after aortic declamping (reperfusion). Parallel blood samples were drawn from the coronary sinus to calculate trans-coronary gradients (coronary sinus-artery). Compared with immediately before aortic declamping, arterial syndecan-1 increased by 18% [253.8 (151.6-372.0) ng/ml vs. 299.1 (172.0-713.7) ng/ml, p < 0.001] but arterial heparan sulfate decreased by 14% [148.1 (135.7-161.7) ng/ml vs. 128.0 (119.0-138.2) ng/ml, p < 0.001] at one minute after aortic declamping. There was no coronary washout of syndecan-1 or heparan sulfate during reperfusion. On the contrary, trans-coronary sequestration of syndecan-1 occurred at five [-12.96 ng/ml (-36.38-5.15), p = 0.007] and at ten minutes [-12.37 ng/ml (-31.80-6.62), p = 0.049] after reperfusion. Aortic declamping resulted in extracardiac syndecan-1 release and extracardiac heparan sulfate sequestration. Syndecan-1 was sequestered in the coronary circulation during early reperfusion. Glycocalyx has been shown to degrade during cardiac surgery. Besides degradation, glycocalyx has propensity for regeneration. The present results of syndecan-1 and heparan sulfate sequestration may reflect endogenous restoration of the damaged glycocalyx in open heart surgery.
doi_str_mv 10.1371/journal.pone.0251747
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2528424790</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A662040708</galeid><doaj_id>oai_doaj_org_article_18a50d08e77d467eaad0942048228ec3</doaj_id><sourcerecordid>A662040708</sourcerecordid><originalsourceid>FETCH-LOGICAL-c692t-24226108e8394864179372ecaf702e5d537e1313638bf334a7bebe528b7c55c63</originalsourceid><addsrcrecordid>eNqNkl1rFDEUhgdRbK3-A9EBQfRi13zNJHMjlFJ1oVDwo7chm5yZzZJNtsmMdP-9WXdadqQXJhcJJ895k3PyFsVrjOaYcvxpHYbolZtvg4c5IhXmjD8pTnFDyawmiD492p8UL1JaI1RRUdfPixNKmzwqclrcXHoT-hU4q1zZuZ0OWrndXWmGaH1XgopuV0bYQmyHZIMvrS-3qrfg-1QO3kDswh7UKhqrdJmG2EHcvSyetcoleDWuZ8WvL5c_L77Nrq6_Li7Or2a6bkg_I4yQGiMBgjZM1AzzhnICWrUcEahMRTlgimlNxbKllCm-hCVURCy5ripd07Pi7UF360KSY0uSJBlhhPEGZWJxIExQa7mNdqPiTgZl5d9AiJ1UsbfagcRCVcjk13BuWM1BKYMaRhAThAjQNGt9Hm8blhswOjchKjcRnZ54u5Jd-C0FJoLUTRb4MArEcDtA6uXGJg3OKQ9hOLxb4ApXPKPv_kEfr26kOpULsL4N-V69F5Xndf55hjgSmZo_QuVpYGN19k9rc3yS8HGSkJke7vpODSnJxY_v_89e30zZ90fsCpTrVym4oc_OSlOQHUAdQ0oR2ocmYyT39r_vhtzbX472z2lvjj_oIene7_QPe_v-8g</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2528424790</pqid></control><display><type>article</type><title>Endothelial glycocalyx during early reperfusion in patients undergoing cardiac surgery</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><source>Public Library of Science (PLoS)</source><creator>Passov, Arie ; Schramko, Alexey ; Salminen, Ulla-Stina ; Aittomäki, Juha ; Andersson, Sture ; Pesonen, Eero</creator><creatorcontrib>Passov, Arie ; Schramko, Alexey ; Salminen, Ulla-Stina ; Aittomäki, Juha ; Andersson, Sture ; Pesonen, Eero</creatorcontrib><description>Experimental cardiac ischemia-reperfusion injury causes degradation of the glycocalyx and coronary washout of its components syndecan-1 and heparan sulfate. Systemic elevation of syndecan-1 and heparan sulfate is well described in cardiac surgery. Still, the events during immediate reperfusion after aortic declamping are unknown both in the systemic and in the coronary circulation. In thirty patients undergoing aortic valve replacement, arterial concentrations of syndecan-1 and heparan sulfate were measured immediately before and at one, five and ten minutes after aortic declamping (reperfusion). Parallel blood samples were drawn from the coronary sinus to calculate trans-coronary gradients (coronary sinus-artery). Compared with immediately before aortic declamping, arterial syndecan-1 increased by 18% [253.8 (151.6-372.0) ng/ml vs. 299.1 (172.0-713.7) ng/ml, p &lt; 0.001] but arterial heparan sulfate decreased by 14% [148.1 (135.7-161.7) ng/ml vs. 128.0 (119.0-138.2) ng/ml, p &lt; 0.001] at one minute after aortic declamping. There was no coronary washout of syndecan-1 or heparan sulfate during reperfusion. On the contrary, trans-coronary sequestration of syndecan-1 occurred at five [-12.96 ng/ml (-36.38-5.15), p = 0.007] and at ten minutes [-12.37 ng/ml (-31.80-6.62), p = 0.049] after reperfusion. Aortic declamping resulted in extracardiac syndecan-1 release and extracardiac heparan sulfate sequestration. Syndecan-1 was sequestered in the coronary circulation during early reperfusion. Glycocalyx has been shown to degrade during cardiac surgery. Besides degradation, glycocalyx has propensity for regeneration. The present results of syndecan-1 and heparan sulfate sequestration may reflect endogenous restoration of the damaged glycocalyx in open heart surgery.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0251747</identifier><identifier>PMID: 33999952</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Acids ; Analysis ; Anesthesiology ; Anticoagulants ; Aorta ; Aortic valve ; Aspirin ; Biology and Life Sciences ; Biomarkers ; Blood circulation ; Blood vessels ; Cardiac patients ; Cardiovascular disease ; Care and treatment ; Catheters ; Coronary artery ; Coronary artery disease ; Coronary circulation ; Editing ; Endothelium ; Engineering and Technology ; Fibrillation ; Glucocorticoids ; Glycocalyx ; Glycosaminoglycans ; Heart ; Heart diseases ; Heart surgery ; Heart valves ; Hemoglobin ; Heparan sulfate ; Immunosuppressive agents ; Intensive care ; Ischemia ; Medicine ; Medicine and Health Sciences ; Methodology ; Pain ; Patients ; Physical Sciences ; Plasma ; Proteins ; Proteoglycans ; Pulmonary arteries ; Reperfusion ; Research facilities ; Rheumatic heart disease ; Surgery ; Syndecan ; Ventricle</subject><ispartof>PloS one, 2021-05, Vol.16 (5), p.e0251747-e0251747</ispartof><rights>COPYRIGHT 2021 Public Library of Science</rights><rights>2021 Passov et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 Passov et al 2021 Passov et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c692t-24226108e8394864179372ecaf702e5d537e1313638bf334a7bebe528b7c55c63</citedby><cites>FETCH-LOGICAL-c692t-24226108e8394864179372ecaf702e5d537e1313638bf334a7bebe528b7c55c63</cites><orcidid>0000-0002-4126-610X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128269/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128269/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,2915,23845,27901,27902,53766,53768,79343,79344</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33999952$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Passov, Arie</creatorcontrib><creatorcontrib>Schramko, Alexey</creatorcontrib><creatorcontrib>Salminen, Ulla-Stina</creatorcontrib><creatorcontrib>Aittomäki, Juha</creatorcontrib><creatorcontrib>Andersson, Sture</creatorcontrib><creatorcontrib>Pesonen, Eero</creatorcontrib><title>Endothelial glycocalyx during early reperfusion in patients undergoing cardiac surgery</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Experimental cardiac ischemia-reperfusion injury causes degradation of the glycocalyx and coronary washout of its components syndecan-1 and heparan sulfate. Systemic elevation of syndecan-1 and heparan sulfate is well described in cardiac surgery. Still, the events during immediate reperfusion after aortic declamping are unknown both in the systemic and in the coronary circulation. In thirty patients undergoing aortic valve replacement, arterial concentrations of syndecan-1 and heparan sulfate were measured immediately before and at one, five and ten minutes after aortic declamping (reperfusion). Parallel blood samples were drawn from the coronary sinus to calculate trans-coronary gradients (coronary sinus-artery). Compared with immediately before aortic declamping, arterial syndecan-1 increased by 18% [253.8 (151.6-372.0) ng/ml vs. 299.1 (172.0-713.7) ng/ml, p &lt; 0.001] but arterial heparan sulfate decreased by 14% [148.1 (135.7-161.7) ng/ml vs. 128.0 (119.0-138.2) ng/ml, p &lt; 0.001] at one minute after aortic declamping. There was no coronary washout of syndecan-1 or heparan sulfate during reperfusion. On the contrary, trans-coronary sequestration of syndecan-1 occurred at five [-12.96 ng/ml (-36.38-5.15), p = 0.007] and at ten minutes [-12.37 ng/ml (-31.80-6.62), p = 0.049] after reperfusion. Aortic declamping resulted in extracardiac syndecan-1 release and extracardiac heparan sulfate sequestration. Syndecan-1 was sequestered in the coronary circulation during early reperfusion. Glycocalyx has been shown to degrade during cardiac surgery. Besides degradation, glycocalyx has propensity for regeneration. The present results of syndecan-1 and heparan sulfate sequestration may reflect endogenous restoration of the damaged glycocalyx in open heart surgery.</description><subject>Acids</subject><subject>Analysis</subject><subject>Anesthesiology</subject><subject>Anticoagulants</subject><subject>Aorta</subject><subject>Aortic valve</subject><subject>Aspirin</subject><subject>Biology and Life Sciences</subject><subject>Biomarkers</subject><subject>Blood circulation</subject><subject>Blood vessels</subject><subject>Cardiac patients</subject><subject>Cardiovascular disease</subject><subject>Care and treatment</subject><subject>Catheters</subject><subject>Coronary artery</subject><subject>Coronary artery disease</subject><subject>Coronary circulation</subject><subject>Editing</subject><subject>Endothelium</subject><subject>Engineering and Technology</subject><subject>Fibrillation</subject><subject>Glucocorticoids</subject><subject>Glycocalyx</subject><subject>Glycosaminoglycans</subject><subject>Heart</subject><subject>Heart diseases</subject><subject>Heart surgery</subject><subject>Heart valves</subject><subject>Hemoglobin</subject><subject>Heparan sulfate</subject><subject>Immunosuppressive agents</subject><subject>Intensive care</subject><subject>Ischemia</subject><subject>Medicine</subject><subject>Medicine and Health Sciences</subject><subject>Methodology</subject><subject>Pain</subject><subject>Patients</subject><subject>Physical Sciences</subject><subject>Plasma</subject><subject>Proteins</subject><subject>Proteoglycans</subject><subject>Pulmonary arteries</subject><subject>Reperfusion</subject><subject>Research facilities</subject><subject>Rheumatic heart disease</subject><subject>Surgery</subject><subject>Syndecan</subject><subject>Ventricle</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNqNkl1rFDEUhgdRbK3-A9EBQfRi13zNJHMjlFJ1oVDwo7chm5yZzZJNtsmMdP-9WXdadqQXJhcJJ895k3PyFsVrjOaYcvxpHYbolZtvg4c5IhXmjD8pTnFDyawmiD492p8UL1JaI1RRUdfPixNKmzwqclrcXHoT-hU4q1zZuZ0OWrndXWmGaH1XgopuV0bYQmyHZIMvrS-3qrfg-1QO3kDswh7UKhqrdJmG2EHcvSyetcoleDWuZ8WvL5c_L77Nrq6_Li7Or2a6bkg_I4yQGiMBgjZM1AzzhnICWrUcEahMRTlgimlNxbKllCm-hCVURCy5ripd07Pi7UF360KSY0uSJBlhhPEGZWJxIExQa7mNdqPiTgZl5d9AiJ1UsbfagcRCVcjk13BuWM1BKYMaRhAThAjQNGt9Hm8blhswOjchKjcRnZ54u5Jd-C0FJoLUTRb4MArEcDtA6uXGJg3OKQ9hOLxb4ApXPKPv_kEfr26kOpULsL4N-V69F5Xndf55hjgSmZo_QuVpYGN19k9rc3yS8HGSkJke7vpODSnJxY_v_89e30zZ90fsCpTrVym4oc_OSlOQHUAdQ0oR2ocmYyT39r_vhtzbX472z2lvjj_oIene7_QPe_v-8g</recordid><startdate>20210517</startdate><enddate>20210517</enddate><creator>Passov, Arie</creator><creator>Schramko, Alexey</creator><creator>Salminen, Ulla-Stina</creator><creator>Aittomäki, Juha</creator><creator>Andersson, Sture</creator><creator>Pesonen, Eero</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-4126-610X</orcidid></search><sort><creationdate>20210517</creationdate><title>Endothelial glycocalyx during early reperfusion in patients undergoing cardiac surgery</title><author>Passov, Arie ; Schramko, Alexey ; Salminen, Ulla-Stina ; Aittomäki, Juha ; Andersson, Sture ; Pesonen, Eero</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c692t-24226108e8394864179372ecaf702e5d537e1313638bf334a7bebe528b7c55c63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Acids</topic><topic>Analysis</topic><topic>Anesthesiology</topic><topic>Anticoagulants</topic><topic>Aorta</topic><topic>Aortic valve</topic><topic>Aspirin</topic><topic>Biology and Life Sciences</topic><topic>Biomarkers</topic><topic>Blood circulation</topic><topic>Blood vessels</topic><topic>Cardiac patients</topic><topic>Cardiovascular disease</topic><topic>Care and treatment</topic><topic>Catheters</topic><topic>Coronary artery</topic><topic>Coronary artery disease</topic><topic>Coronary circulation</topic><topic>Editing</topic><topic>Endothelium</topic><topic>Engineering and Technology</topic><topic>Fibrillation</topic><topic>Glucocorticoids</topic><topic>Glycocalyx</topic><topic>Glycosaminoglycans</topic><topic>Heart</topic><topic>Heart diseases</topic><topic>Heart surgery</topic><topic>Heart valves</topic><topic>Hemoglobin</topic><topic>Heparan sulfate</topic><topic>Immunosuppressive agents</topic><topic>Intensive care</topic><topic>Ischemia</topic><topic>Medicine</topic><topic>Medicine and Health Sciences</topic><topic>Methodology</topic><topic>Pain</topic><topic>Patients</topic><topic>Physical Sciences</topic><topic>Plasma</topic><topic>Proteins</topic><topic>Proteoglycans</topic><topic>Pulmonary arteries</topic><topic>Reperfusion</topic><topic>Research facilities</topic><topic>Rheumatic heart disease</topic><topic>Surgery</topic><topic>Syndecan</topic><topic>Ventricle</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Passov, Arie</creatorcontrib><creatorcontrib>Schramko, Alexey</creatorcontrib><creatorcontrib>Salminen, Ulla-Stina</creatorcontrib><creatorcontrib>Aittomäki, Juha</creatorcontrib><creatorcontrib>Andersson, Sture</creatorcontrib><creatorcontrib>Pesonen, Eero</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Passov, Arie</au><au>Schramko, Alexey</au><au>Salminen, Ulla-Stina</au><au>Aittomäki, Juha</au><au>Andersson, Sture</au><au>Pesonen, Eero</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Endothelial glycocalyx during early reperfusion in patients undergoing cardiac surgery</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2021-05-17</date><risdate>2021</risdate><volume>16</volume><issue>5</issue><spage>e0251747</spage><epage>e0251747</epage><pages>e0251747-e0251747</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Experimental cardiac ischemia-reperfusion injury causes degradation of the glycocalyx and coronary washout of its components syndecan-1 and heparan sulfate. Systemic elevation of syndecan-1 and heparan sulfate is well described in cardiac surgery. Still, the events during immediate reperfusion after aortic declamping are unknown both in the systemic and in the coronary circulation. In thirty patients undergoing aortic valve replacement, arterial concentrations of syndecan-1 and heparan sulfate were measured immediately before and at one, five and ten minutes after aortic declamping (reperfusion). Parallel blood samples were drawn from the coronary sinus to calculate trans-coronary gradients (coronary sinus-artery). Compared with immediately before aortic declamping, arterial syndecan-1 increased by 18% [253.8 (151.6-372.0) ng/ml vs. 299.1 (172.0-713.7) ng/ml, p &lt; 0.001] but arterial heparan sulfate decreased by 14% [148.1 (135.7-161.7) ng/ml vs. 128.0 (119.0-138.2) ng/ml, p &lt; 0.001] at one minute after aortic declamping. There was no coronary washout of syndecan-1 or heparan sulfate during reperfusion. On the contrary, trans-coronary sequestration of syndecan-1 occurred at five [-12.96 ng/ml (-36.38-5.15), p = 0.007] and at ten minutes [-12.37 ng/ml (-31.80-6.62), p = 0.049] after reperfusion. Aortic declamping resulted in extracardiac syndecan-1 release and extracardiac heparan sulfate sequestration. Syndecan-1 was sequestered in the coronary circulation during early reperfusion. Glycocalyx has been shown to degrade during cardiac surgery. Besides degradation, glycocalyx has propensity for regeneration. The present results of syndecan-1 and heparan sulfate sequestration may reflect endogenous restoration of the damaged glycocalyx in open heart surgery.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>33999952</pmid><doi>10.1371/journal.pone.0251747</doi><tpages>e0251747</tpages><orcidid>https://orcid.org/0000-0002-4126-610X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2021-05, Vol.16 (5), p.e0251747-e0251747
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_2528424790
source DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Free Full-Text Journals in Chemistry; Public Library of Science (PLoS)
subjects Acids
Analysis
Anesthesiology
Anticoagulants
Aorta
Aortic valve
Aspirin
Biology and Life Sciences
Biomarkers
Blood circulation
Blood vessels
Cardiac patients
Cardiovascular disease
Care and treatment
Catheters
Coronary artery
Coronary artery disease
Coronary circulation
Editing
Endothelium
Engineering and Technology
Fibrillation
Glucocorticoids
Glycocalyx
Glycosaminoglycans
Heart
Heart diseases
Heart surgery
Heart valves
Hemoglobin
Heparan sulfate
Immunosuppressive agents
Intensive care
Ischemia
Medicine
Medicine and Health Sciences
Methodology
Pain
Patients
Physical Sciences
Plasma
Proteins
Proteoglycans
Pulmonary arteries
Reperfusion
Research facilities
Rheumatic heart disease
Surgery
Syndecan
Ventricle
title Endothelial glycocalyx during early reperfusion in patients undergoing cardiac surgery
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T05%3A35%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Endothelial%20glycocalyx%20during%20early%20reperfusion%20in%20patients%20undergoing%20cardiac%20surgery&rft.jtitle=PloS%20one&rft.au=Passov,%20Arie&rft.date=2021-05-17&rft.volume=16&rft.issue=5&rft.spage=e0251747&rft.epage=e0251747&rft.pages=e0251747-e0251747&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0251747&rft_dat=%3Cgale_plos_%3EA662040708%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2528424790&rft_id=info:pmid/33999952&rft_galeid=A662040708&rft_doaj_id=oai_doaj_org_article_18a50d08e77d467eaad0942048228ec3&rfr_iscdi=true